Ketamine Completed Phase 3 Trials for Pain / Inflammatory Responses / Hyperalgesia Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01301079Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia